Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5QET
|
||||
| Drug Name |
2-(3-phenyl-1-(3-(trifluoromethyl)phenyl)allylidene)hydrazinecarbothioamide
|
||||
| Synonyms |
CHEMBL404938
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C17H14F3N3S
|
||||
| Canonical SMILES |
NC(=S)N\\N=C(\\C=C\\c1ccccc1)/c2cccc(c2)C(F)(F)F
|
||||
| InChI |
InChI=1S/C17H14F3N3S/c18-17(19,20)14-8-4-7-13(11-14)15(22-23-16(21)24)10-9-12-5-2-1-3-6-12/h1-11H,(H3,21,23,24)/b10-9+,22-15-
|
||||
| InChIKey |
ONATVUQYXQRQNA-QTGMJVSOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.